Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling

被引:4
|
作者
Lu, Qiqi [1 ,2 ,3 ]
Nie, Rongfang [1 ,2 ,3 ]
Luo, Jiangti [1 ,2 ,3 ]
Wang, Xiaosheng [1 ,2 ,3 ]
You, Linjun [4 ]
机构
[1] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Biomed Informat Res Lab, Nanjing 211198, Peoples R China
[2] China Pharmaceut Univ, Canc Genom Res Ctr, Sch Basic Med & Clin Pharm, Nanjing 211198, Peoples R China
[3] China Pharmaceut Univ, Big Data Res Inst, Nanjing 211198, Peoples R China
[4] China Pharmaceut Univ, Ctr New Drug Safety Evaluat & Res, Nanjing 211198, Peoples R China
关键词
adrenocortical carcinoma; immunological classification; clustering analysis; steroid hormones; tumor immune microenvironment; PROGNOSTIC VALUE; ANALYSIS REVEALS; DNA-DAMAGE; CANCER; EXPRESSION; TUMORS; CLASSIFICATION; IMMUNOTHERAPY; BLOCKADE; PATHWAY;
D O I
10.3390/biom13010104
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The tumor immune microenvironment (TIME) of adrenocortical carcinoma (ACC) is heterogeneous. However, a classification of ACC based on the TIME remains unexplored. Methods: We hierarchically clustered ACC based on the enrichment levels of twenty-three immune signatures to identify its immune-specific subtypes. Furthermore, we comprehensively compared the clinical and molecular profiles between the subtypes. Results: We identified two immune-specific subtypes of ACC: Immunity-H and Immunity-L, which had high and low immune signature scores, respectively. We demonstrated that this subtyping method was stable and reproducible by analyzing five different ACC cohorts. Compared with Immunity-H, Immunity-L had lower levels of immune cell infiltration, worse overall and disease-free survival prognosis, and higher tumor stemness, genomic instability, proliferation potential, and intratumor heterogeneity. Furthermore, the ACC driver gene CTNNB1 was more frequently mutated in Immunity-L than in Immunity-H. Several proteins, such as mTOR, ERCC1, Akt, ACC1, Cyclin_E1, beta-catenin, FASN, and GAPDH, were more highly expressed in Immunity-L than in Immunity-H. In contrast, p53, Syk, Lck, PREX1, and MAPK were more highly expressed in Immunity-H. Pathway and gene ontology analysis showed that the immune, stromal, and apoptosis pathways were highly enriched in Immunity-H, while the cell cycle, steroid biosynthesis, and DNA damage repair pathways were highly enriched in Immunity-L. Conclusions: ACC can be classified into two stable immune-related subtypes, which have significantly different antitumor responses, molecular characteristics, and clinical outcomes. This subtyping may provide clinical implications for prognostic and immunotherapeutic stratification of ACC.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Viral Transcript and Tumor Immune Microenvironment-Based Transcriptomic Profiling of HPV-Associated Head and Neck Squamous Cell Carcinoma Identifies Subtypes Associated with Prognosis
    Nikitina, Anastasiia
    Kiriy, Daria
    Tyshevich, Andrey
    Tychinin, Dmitry
    Antysheva, Zoya
    Sobol, Anastasya
    Kushnarev, Vladimir
    Shin, Nara
    Brown, Jessica H.
    Lewis Jr, James
    Kuhs, Krystle A. Lang
    Ferris, Robert
    Wirth, Lori
    Kotlov, Nikita
    Faden, Daniel L.
    VIRUSES-BASEL, 2025, 17 (01):
  • [42] Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients
    Xiong, Ying
    Wang, Zewei
    Zhou, Quan
    Zeng, Han
    Zhang, Hongyu
    Liu, Zhaopei
    Huang, Qiuren
    Wang, Jiajun
    Chang, Yuan
    Xia, Yu
    Wang, Yiwei
    Liu, Li
    Zhu, Yu
    Xu, Le
    Dai, Bo
    Bai, Qi
    Guo, Jianming
    Xu, Jiejie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [43] Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs
    Zhang, Cunzhen
    Wang, Jiyao
    Jia, Lin
    Wen, Qiang
    Gao, Na
    Qiao, Hailing
    BIOMEDICINES, 2025, 13 (01)
  • [44] Identification of Proteome-Based Immune Subtypes of Early Hepatocellular Carcinoma and Analysis of Potential Metabolic Drivers
    Diao, Lihong
    He, Mengqi
    Xu, Binsheng
    Chen, Lanhui
    Wang, Ze
    Yang, Yuting
    Xia, Simin
    Hu, Shengwei
    Guo, Shuzhen
    Li, Dong
    MOLECULAR & CELLULAR PROTEOMICS, 2024, 23 (01)
  • [45] Protein- and sequencing-based massively parallel single-cell approaches to immune profiling asthma-specific cell subtypes and related gene expression biomarkers
    Ji, Xuhuai
    Acharya, Swati
    Goncharov, Igor
    Lyu, Shu-Chen
    Miranda, Molly
    Padalon-Brauch, Gilly
    Nadeau, Kari Christine
    Maecker, Holden T.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [46] High-Resolution Profiling of Head and Neck Squamous Cells Carcinoma Identifies Specific Biomarkers and Expression Subtypes of Clinically Relevant Vulnerabilities
    Zhu, Yingying
    Peng, Bi
    Luo, Xiaoxiao
    Sun, Wei
    Liu, Dongbo
    Li, Na
    Qiu, Ping
    Long, Guoxian
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (17) : 2431 - 2448
  • [47] SINGLE-CELL PROFILING WITH REGARD TO DISEASE SEVERITY DEFINES SPECIFIC IMMUNE CELL SUBTYPES AND THEIR INFLUENCE ON SKIN STROMAL CELLS IN ATOPIC DERMATITIS
    Roesner, Lennart M.
    Traidl, Stephan
    Zhang, Bowen
    Koeken, Valerie A. C. M.
    Xu, Chengjian
    Li, Yang
    Werfel, Thomas
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 24 - 24
  • [48] Magnetic bead-based serum peptidome profiling for identifying potential biomarkers in esophageal squamous cell carcinoma
    Jia, Kun
    Li, Wei
    Wang, Feng
    Liu, Fang
    Liu, Xiaofei
    Qiao, Yuanyuan
    Xu, Yang
    Zhou, Lanping
    Sun, Yulin
    Ma, Qingwei
    Zhao, Xiaohang
    CANCER RESEARCH, 2015, 75
  • [49] Identifying subtypes and developing prognostic models based on N6-methyladenosine and immune microenvironment related genes in breast cancer
    Wang, Lizhao
    Li, Jianpeng
    Mei, Nan
    Chen, Heyan
    Niu, Ligang
    He, Jianjun
    Wang, Ru
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
    Qiuxian Zheng
    Qin Yang
    Jiaming Zhou
    Xinyu Gu
    Haibo Zhou
    Xuejun Dong
    Haihong Zhu
    Zhi Chen
    Cancer Cell International, 21